The neuroprotective role of melatonin in neurological disorders

被引:168
作者
Alghamdi, B. S. [1 ,2 ]
机构
[1] King Abdulaziz Univ, Fac Med, Dept Physiol, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ, Fac Med, Neurosci Unit, Jeddah, Saudi Arabia
关键词
melatonin; ischemia; alzheimer; parkinson; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; FAMILIAL ALZHEIMERS-DISEASE; OXIDATIVE STRESS HYPOTHESIS; MAMMALIAN PINEAL-GLAND; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID;
D O I
10.1002/jnr.24220
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Melatonin is a neurohormone secreted from the pineal gland and has a wide-ranging regulatory and neuroprotective role. It has been reported that melatonin level is disturbed in some neurological conditions such as stroke, Alzheimer's disease, and Parkinson's disease, which indicates its involvement in the pathophysiology of these diseases. Its properties qualify it to be a promising potential therapeutic neuroprotective agent, with no side effects, for some neurological disorders. This review discusses and localizes the effect of melatonin in the pathophysiology of some diseases.
引用
收藏
页码:1136 / 1149
页数:14
相关论文
共 200 条
  • [1] Acuna-Castroviejo Dario, 1997, Life Sciences, V60, pPL23
  • [2] Adi N, 2010, MED SCI MONITOR, V16, pBR61
  • [4] Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition
    Alluri, Himakarnika
    Wilson, Rickesha L.
    Shaji, Chinchusha Anasooya
    Wiggins-Dohlvik, Katie
    Patel, Savan
    Liu, Yang
    Peng, Xu
    Beeram, Madhava R.
    Davis, Matthew L.
    Huang, Jason H.
    Tharakan, Binu
    [J]. PLOS ONE, 2016, 11 (05):
  • [5] Alvarez A, 1998, J NEUROSCI, V18, P3213
  • [6] Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study
    Aly, H.
    Elmandy, H.
    El-Dib, M.
    Rowisha, M.
    Awny, M.
    El-Gohary, T.
    Elbatcht, M.
    Hamisa, M.
    El-Mashad, A-R
    [J]. JOURNAL OF PERINATOLOGY, 2015, 35 (03) : 186 - 191
  • [7] Protective effect of melatonin in a chronic experimental model of Parkinson's disease
    Antolín, I
    Mayo, JC
    Sainz, RM
    del Brío, MD
    Herrera, F
    Martín, V
    Rodríguez, C
    [J]. BRAIN RESEARCH, 2002, 943 (02) : 163 - 173
  • [8] IMMUNOASSAY OF 6-HYDROXYMELATONIN SULFATE IN HUMAN-PLASMA AND URINE - ABOLITION OF THE URINARY 24-HOUR RHYTHM WITH ATENOLOL
    ARENDT, J
    BOJKOWSKI, C
    FRANEY, C
    WRIGHT, J
    MARKS, V
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06) : 1166 - 1173
  • [9] Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
    Arundine, M
    Tymianski, M
    [J]. CELL CALCIUM, 2003, 34 (4-5) : 325 - 337
  • [10] Baldeiras I, 2008, J ALZHEIMERS DIS, V15, P117